Congress orders health care AI study—but who shapes the findings?
H.R. 7064 — AI in Health Care Efficiency and Study Act · Filed by Pablo José Hernández Rivera (D-PR) · 2 cosponsors · Introduced Jan 14, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to study how artificial intelligence can reduce administrative burden in health care—such as scheduling, claims processing, and prior authorization—while protecting patient privacy. The study must be completed within 18 months, followed by a report to Congress with findings, risk assessments, and policy recommendations for AI oversight in health care.
Why we flagged it
The bill is fundamentally a directive for a government study and report on AI applications in health care administration. It creates no new regulatory authority, no direct spending, and no industry carve-outs—only a fact-finding exercise with explicit privacy safeguards.
What the text implies
- Study findings and policy recommendations may later inform regulatory or legislative action that could favor certain AI vendors or health care IT companies over others, depending on which technologies are deemed most effective.
- The consultation requirement includes 'artificial intelligence developers,' creating a channel for industry input into government recommendations—potential for soft capture if developer interests dominate the advisory process.
The full analysis lists 4 implications of this text.
Who stands to gain
health care IT vendors; artificial intelligence developers; health care providers (via efficiency gains)